share_log

アステラス製薬:VYLOY(ゾルベツキシマブ) 局所進行性または転移性胃腺がんおよび 食道胃接合部腺がんに対する化学療法との併用として 欧州で承認取得

Astellas Pharma: VYLOY (zolbetuximab) approved in Europe for use in combination with chemotherapy for locally advanced or metastatic gastric adenocarcinoma and esophagogastric junction adenocarcinoma

JPX ·  Sep 24, 2024 07:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more